To view this email as a web page, click here.
 
 
Tipifarnib Shows Responses in HRAS-Mutant Head and Neck Cancers
A new inhibitor may help patients with a certain subset of head and neck squamous cell carcinoma.
Read more
 
 
Selumetinib Clinically Improves NF1-Associated Neurofibromas
The worldwide incidence, and death toll, of colorectal and pancreatic cancers have sharply increased since 1990, according to the results of a new study.
Read more
 
 
IN CASE YOU MISSED IT
 
Analysis of Cervical Mutations Aids Endometrial Cancer Diagnosis
Diagnosis of endometrial carcinoma made easier by analysis of mutations in cervix or endometrial tissue.
Read more
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.